Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents
Publication
, Conference
Ross, JS; Wang, K; Gay, LM; Al-Rohil, RN; Nazeer, T; Sheehan, CE; Jennings, TA; Otto, GA; Donahue, A; He, J; Palmer, G; Ali, S; Nahas, M ...
Published in: LABORATORY INVESTIGATION
February 1, 2014
Duke Scholars
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
February 1, 2014
Volume
94
Start / End Page
256A / 256A
Location
San Diego, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ross, J. S., Wang, K., Gay, L. M., Al-Rohil, R. N., Nazeer, T., Sheehan, C. E., … Stephens, P. J. (2014). Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents. In LABORATORY INVESTIGATION (Vol. 94, pp. 256A-256A). San Diego, CA: NATURE PUBLISHING GROUP.
Ross, J. S., K. Wang, L. M. Gay, R. N. Al-Rohil, T. Nazeer, C. E. Sheehan, T. A. Jennings, et al. “Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents.” In LABORATORY INVESTIGATION, 94:256A-256A. NATURE PUBLISHING GROUP, 2014.
Ross JS, Wang K, Gay LM, Al-Rohil RN, Nazeer T, Sheehan CE, et al. Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents. In: LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2014. p. 256A-256A.
Ross, J. S., et al. “Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents.” LABORATORY INVESTIGATION, vol. 94, NATURE PUBLISHING GROUP, 2014, pp. 256A-256A.
Ross JS, Wang K, Gay LM, Al-Rohil RN, Nazeer T, Sheehan CE, Jennings TA, Otto GA, Donahue A, He J, Palmer G, Ali S, Nahas M, Young G, LaBrecque E, Frampton G, Erlich R, Curran JA, Brennan K, Downing SR, Yelensky R, Lipson D, Hawryluk M, Miller VA, Stephens PJ. Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents. LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2014. p. 256A-256A.
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
February 1, 2014
Volume
94
Start / End Page
256A / 256A
Location
San Diego, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences